Search

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

V
Vaanaanen H. - P-Selectin deficiency results in impaired thrombus formation and frequent embolization in mouse model of carotid artery thrombosis
Vaccarino A. - Prolonged APTT children undergoing elective tonsillectomy
  - Anti-protein S antibodies in patients with venous and/or arterial thrombosis
Vadasz Z. - Warfarin and overanticoagulation
Vaidyula V. R. - Anti-platelet agents clopidogrel and aspirin inhibit expression of tissue factor procoagulant activity in patients with peripheral artery disease
Vaigot P. - A study of gene expression profiles during megakaryocytopoiesis
Vainchenker W. - Cross-talk between alpha2beta1 integrin and GPVI receptors regulates actin polymerization through Rho GTPase and MAP kinase Erk1/2 signaling pathways in human megakaryocytes
Vaitkus P. T. - A randomized placebo controlled trial of dalteparin for the prevention of venous thromboembolism in 3706 acutely Ill medical patients: the PREVENT medical thromboprophylaxis study
Vajda S. - Thrombin receptors on the cells of the blood–brain barrier
Valarani B. - A clinical outcome-based prospective study on venous thromboembolism in cancer surgery: the @RISTOS project
Valdre L. - Thrombophilia and residual vein thrombosis are independent risk factors for recurrent venous thromboembolism
  - D-dimer and residual vein thrombosis assessed at 3 months after anti-coagulation withdrawal are independent risk factors for recurrent venous thromboembolism
Valdrè L. - The risk of recurrence after a first episode of venous thromboembolism in cancer patients
Valdre L. - Venous thromboembolic complications in patients with multiple myeloma treated with thalidomide:prophylatic effect of fixed dose Wafarin L
Valenti G. - Diagnosis of deep vein thrombosis in hospitalized elderly patients: poor discriminant value of clinical pretest probability unless integrated by d-dimer assay
Valentini G. - Increased intima-media thickness to show relationship between atherosclerosis and inflammation in a human model: patients affected by rheumatoid arthritis and absence of common markers of atherosclerosis
Valentino L. A. - Type 2 M von Willebrand disease due to linked P1266Q and V1279I substitutions in the von Willebrand factor A1 domain
Valentino L. - Low-molecular-weight heparin dose requirements are age-related through childhood
Valention L. A. - Enhancing hemophilia care and patient adherence using Advoy.com
Vallés J. - Platelet–erythrocyte interactions enhance GPIIbIIIa receptor activation and P-selectin expression during platelet recruitment. These effects are amplified in type I diabetic patients
Vallés J. - Insufficient thromboxane A2 inhibition in patients with vascular disease chronically treated with aspirin: implications for platelet function
Vallez M. O. - Evolution of a nonocclusive deep vein thrombosis in the rabbit vena cava
Vallez M. O. - Anti-thrombotic and anticoagulant effects of S35898 an orally active thrombin inhibitor
Valliere J. - Asymptomatic venous thrombosis is a frequent event in protein C deficiency: a systematic ultrasound assessment of 208 family members with the 3363-C insertion mutation (IPCI: International Protein C Investigation)
Vallve C. - The 46C®T polymorphism in the F12 gene as a risk factor for venous thrombosis: association after linkage analysis
  - Complexity of the genetic contribution to Factor VII deficiency in two Spanish families: clinical and biological implications
  - Genetic dissection of thrombin-activatable fibrinolysis inhibitor (TAFI)
  - The 46C®T polymorphism in F12 gene is a risk factor for coronary artery disease
  - The 46C®T polymorphism in the F12 gene is a risk factor for ischemic stroke
Valsecchi C. - Standardization of activated protein C resistance testing: effect of residual platelets in frozen plasmas assessed with commercial and home made methods
Van Aarle F. G. B. - Two sensitive chromogenic assays of fondaparinux sodium (Arixtra®), a new synthetic and selective inhibitor of factor Xa, in plasma
Van Aken B. E. - Symptomatic plaques of type 2 diabetic patients show more plaque complications but similar expression patterns of markers for coagulation and inflammation compared to nondiabetic controls
Van Aken H. - Thrombospondin-1 promotes transendothelial migration of monocytes associated with platelets
Van Aken B. - Recombinant factor VIIa reverses the anticoagulant effect of the long-acting pentasaccharide idraparinux in healthy volunteers
Van Amsterdam R. G. M. - Potential reversal agents for the long-acting pentasaccharide idraparinux
Van Assche K. W. A. - Endogenous factor V synthesis in megakaryocytes contributes negligibly to the platelet factor V pool
Van Beek E. J. R. - Long-term follow-up of patients with suspected deep vein thrombosis of the upper extremities: survival, risk factors and post–thrombotis syndrome
Van Belle E. - Tissue factor predicts long-term outcome after percutaneous coronary revascularization
  - Tissue factor pathway in carotid atherosclerotic plaques: relationships with clinical patterns and risk factors
  - Effect of in vivo thrombin inhibition on bFGF-induced angiogenesis in a murine angiogenic model
Van Cott E.* - The effect of drotrecogin alfa (Xigris) on the biphasic PTT waveform in patients with sepsis
Van Cott E. M. - Biphasic PTT waveform and adverse events in nonintensive care unit patients
Van De Poel M. - Risk assessment of venous thromboembolism in pregnant women with factor V Leiden, prothrombin 20210 A mutation, elevated factor VIII levels or mild hyperhomocystinaemia
Van De Ree M. A. - Atorvastatin strongly reduces C-reactive protein, but shows less marked effect on other prognostic inflammatory markers
  - Decrease of thrombophilia variables by aggressive vs. conventional atorvastatin treatment in patients with type 2 diabetes mellitus
Van De Water N. - Protein Z-dependent protease inhibitor (ZPI) deficiency: a new thrombotic risk factor?
Van De Werf F. - Combination therapy with low-molecular weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)
  - Combination therapy with low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)
Van De Wouwer M. - Establishing links between coagulation and inflammation: The lectin-like domain of thrombomodulin confers protection in a murine model of rheumatoid arthritis
Van Den Berg H. M. - The relation between clinical phenotype and genotype of severe hemophilia A
Van Den Berg E. - Duplex screening for quality assurance of postoperative thromboembolism prophylaxis in neurosurgery – Krefeld Study ‘Thrombo 2000’
Van Den Berg H. M. - Effects of bleeds on health-related quality of life in patients with hemophilia
Van Den Berk N. - a4 integrins and P-selectin mediate rolling and initial attachment of platelet-monocyte complexes to activated endothelium under flow conditions
Van Den Berkmortel F. W. P. J. - Homocysteine concentrations are associated with increased t-PA and PAI concentrations in smokers
Van Den Besselaar A. M. H. P. - European action on anti-coagulation – cost effectiveness of computer assisted anti-coagulant dosage
  - European concerted action on anti-coagulation (ECAA). Correction of displayed INR on two point-of-care test (POCT) whole blood prothrombin time monitors (CoaguChek Mini and TAS PT-NC) by independent International Sensitivity Index (ISI) calibration
  - European concerted action on anti-coagulation (ECAA). reliability of International Normalized Ratios (INR) from CoaguChek mini and TAS PT-NC whole blood point-of-care test monitor systems
Van Den Blink B. - Coagulation factor profiles respond strongly during human endotoxemia
Van Den Ende A. E. - Alterations in lipoprotein homeostasis during experimental and clinical sepsis in primates
Van Den Heuvel M. W. - Two sensitive chromogenic assays of fondaparinux sodium (Arixtra®), a new synthetic and selective inhibitor of factor Xa, in plasma
Van Der A. D. - Coronary risk prediction and the role of C-reactive protein
Van Der Berg M. - Outcome measures in hemophilia: a physician's perspective
Van Der Bom J. G. - The relation between clinical phenotype and genotype of severe hemophilia A
Van Der Bom J. G. - Coronary risk prediction and the role of C-reactive protein
Van Der Bom J. G. - Effects of bleeds on health-related quality of life in patients with hemophilia
Van Der Graaf Y. - Procoagulant factors and the risk of myocardial infraction in young women
Van Der Heide Y. T. - A two-stage thrombophilia screening protocol: more efficient use of laboratory tests
Van Der Heijden J. F. - CYP2C9 polymorphisms have differential effects on acenocoumarol metabolism, but do not increase bleeding risk
van der Heijden J. - PT20210 and Factor V Leiden mutations are not protective against bleeding during treatment with vitamin K antagonists
Van Der Heijden J. - CYP2C9 polymorphisms have differential effects on the quality of acenocoumarol treatment
Van Der Heul C. - Diagnostic performances of two new d-dimer assays in the diagnostic work-up of patients with suspected pulmonary emboli
Van Der Horst-Bruinsma I. E. - Thromboprophylaxis in orthopedic surgery: Clinical practice in the Netherlands
Van Der Kuip D. A. M. - Association between genetic variability of von Willebrand factor and peripheral atherosclerosis: the Rotterdam Study
  - Genetic variability of von Willebrand factor and coronary heart disease: the Rotterdam Study
Van Der Linden M. - A novel method to accurately measure collagen/serotonin-induced platelet aggregation by whole blood impedance aggregometry in humans
Van Der Linden I. - Preconceptional, gestational and puerperal low anti-annexin A5 antibody levels in women who develop pre-eclampsia
Van Der Meer J. - Venous and arterial thromboembolic risk in first degree family members of patients with elevated plasma levels of clotting factor VIII:c
  - Absolute risk of venous and arterial thromboembolism associated with mild hyperhomocysteinemia. Preliminary results of a family cohort study
  - High-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in congenital coagulation disorders. A randomized, double-blind, placebo-controlled clinical trial
Van Der Meer F. J. M. - European action on anti-coagulation – cost effectiveness of computer assisted anti-coagulant dosage
Van Der Meer J. - Individual variations of the level of oral anticoagulation in patients with venous thromboembolism (VTE) as predictor of clinical outcome
  - Arterial thromboembolism (ATE) in patients with systemic lupus erythematosus (SLE): the contribution of inherited thrombophilic risk factors
  - The risk of pregnancy complications in women from families with thrombophilic defects
Van Der Meer I. M. - Association between genetic variability of von Willebrand factor and peripheral atherosclerosis: the Rotterdam Study
Van Der Meer F. J. M. - Common genetic abnormalities in blood coagulation (Factor V Leiden, prothrombin G20210A) increase the incidence of central vein catheter related thrombosis
Van Der Meer J. - The contribution of inherited thrombophilic risk factors to venous thromboembolism (VTE) in patients with systemic lupus erythematosus (SLE)
  - Increased risk for venous thromboembolism and myocardial infarction in family members of patients with prothrombin 20210 A mutation
Van Der Meer I. M. - Genetic variability of von Willebrand factor and coronary heart disease: the Rotterdam Study
Van Der Meer J. - Risk assessment of venous thromboembolism in pregnant women with factor V Leiden, prothrombin 20210 A mutation, elevated factor VIII levels or mild hyperhomocystinaemia
  - Absolute risk of venous thromboembolism (VTE) associated with a single or combined thrombophilic disorder. Preliminary results of a family cohort study
Van Der Meer F. J. M. - Incidence of venous thrombosis in carriers of familial thrombophilia with a personal history of venous thrombosis
Van Der Neut Kolfschoten M. - Activated factor V is inactivated by activated protein C in the absence of APC cleavage sites at Arg306, Arg506 and Arg679
  - Characterization of an immunologic polymorphism in the heavy chain of human factor V, due to a dimorphism of residue 79
Van Der Poll T. - Inhibition of plasmin activity by tranexamic acid does not influence inflammatory pathways during human endotoxemia
  - Coagulation factor profiles respond strongly during human endotoxemia
  - Plasminogen activator inhibitor type I-deficient (PAI–/–) mice show an improved early host defense in E. coli peritonitis by a neutrophil-dependent mechanism
Van Der Schouw Y. T. - Coronary risk prediction and the role of C-reactive protein
Van Der Spoel J. I. - Lepirudin anti-coagulation in critically ill patients with (suspected) heparin-induced thrombocytopenia and thrombosis
Van Der Straaten H. M. - Elevated levels of d-dimer and fragment 1 + 2 upon central venous catheter insertion and factor V Leiden predict subclavian vein thrombosis
Van Der Ven-Jongekrijg J. - IL-6 concentration in the acute phase of deep-vein thrombosis is a strong predictor of elevated venous outflow resistance as a proxy of post-trombotic syndrome
Van Der Vorst M. M. J. - Evaluation of a bed-side device to assess the APTT for heparin monitoring in infants
Van Der Wal A. C. - Symptomatic plaques of type 2 diabetic patients show more plaque complications but similar expression patterns of markers for coagulation and inflammation compared to nondiabetic controls
Van Der Zee M. - Recombinant truncated tissue factor triggers coagulation in normal human plasma via the extrinsic pathway
Van Der Zwaan C. - Exposure of a binding site for the low-density lipoprotein receptor-related protein (LRP) upon activation of factor V
Van Deventer S. J. - Alterations in lipoprotein homeostasis during experimental and clinical sepsis in primates
Van Dijk K. - The relation between clinical phenotype and genotype of severe hemophilia A
Van Dijk K. - Effects of bleeds on health-related quality of life in patients with hemophilia
Van Dinther T. G. - Two sensitive chromogenic assays of fondaparinux sodium (Arixtra®), a new synthetic and selective inhibitor of factor Xa, in plasma
Van Dongen C. J. J. - The optimal duration of treatment with vitamin K antagonists in patients with a first episode of venous thromboembolism: a decision analytic approach
Van Dreden P. - The role of tissue factor on the inhibition of prothrombin activation and thrombin generation by the synthetic pentasaccharide (fondaparinux)
  - Normal values of total and free TFPI levels in the newborn and in children
  - Measurement of synthetic pentasaccharide fondaparinux (arixtra) anti-Xa activity
  - The role of tissue factor on the inhibition of prothrombin activation and thrombin generation by the synthetic pentasaccharide (fondaparinux)
  - Genetic analysis of hereditary factor X deficiency in a French patient of Sri Lanka ancestry: in vitro expression study identified Gly366Ser substitution as the molecular basis of the dysfunctional factor X
Van Eck A. T. C. J. - Duplex screening for quality assurance of postoperative thromboembolism prophylaxis in neurosurgery – Krefeld Study ‘Thrombo 2000’
Van Geest-Daalderop J. H. H. - Age and first INR after standard initiation of oral anti-coagulant therapy with acenocoumarol predict the maintenance dosage
  - Relation between compliance and quality of treatment with vitamin K antagonists
Van Geet C. - The Gs agonist PACAP(1–38) is a physiological inhibitor of platelet aggregation and megakaryocyte maturation
  - Functional polymorphisms in the paternally expressed XLas and its cofactor ALEX decrease their mutual interaction and enhance receptor-mediated cAMP formation resulting in platelet Gs hyperfunction
Van Gestel M. A. - In vivo involvement of ADP in thromboembolism through its receptors P2Y1 and P2Y12
Van Gorp E. C. M. - Coagulation abnormalities in dengue virus infections: more common than currently perceived?
Van Gorp C. - Pharmacodynamic profile of Intimatan as an antithrombotic agent for venous thrombosis
  - Intimatan ameliorates the activation of human platelets by heparin/heparin antibody from patients with heparin-induced thrombocytopenia
Van Gorp E. C. M. - Endothelial cell and monocyte-derived microparticles in severe dengue virus infections
Van Gulik T. M. - Factor VIII expression in liver disease
Van Heerde W. L. - Screening for annexin A5 gene mutations and the risk of the C-1T mutation in venous thrombosis and myocardial infarction
Van Heerde W. - Preconceptional, gestational and puerperal low anti-annexin A5 antibody levels in women who develop pre-eclampsia
  - Long-term in vivo platelet presensitization may explain the mechanism of factor VIIa prophylaxis in factor VII-deficient patients
Van Heerde W. L. - The Nijmegen low-titer factor VIII inhibitor assay: a highly sensitive assay for the detection of low-titer factor VIII inhibitors
Van Heerde W. - The presence of antiphospholipid antibodies is not related to increased levels of annexin A5 in plasma
  - Evaluation of the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic approach to determine Glanzmann Thrombasthenia in blood platelet lysates
Van Helden P. M. W. - A mouse model for inhibitor development in mild hemophilia A
Van Hulsteijn L. H. - A prospective implementation study of out-patient treatment with subcutaneous low-molecular-weight heparin and oral anti-coagulants in patients with deep venous thrombosis in routine clinical practice
Van Hylckama Vlieg A. - The thrombotic risk of different types of oral contraceptives and interaction with factor V Leiden and the prothrombin 20210 A mutation: results of the MEGA study
Van Hylckama Vlieg A. - Estrogens, progestogens and thrombosis
Van Kampen R. - Effects of platelet agonists and antiplatelet agents on thrombin formation in human plasma
Van Korlaar I. - Lower degree of protein C activation in protein C deficient individuals of a large kindred with type I PC deficiency, as measured by the level of APC-PCI complex
Van Korlaar I. M. - Questioning the questionnaire: a sensitivity analysis for data collection on venous thrombosis
Van Korlaar I. - Asymptomatic venous thrombosis is a frequent event in protein C deficiency: a systematic ultrasound assessment of 208 family members with the 3363-C insertion mutation (IPCI: International Protein C Investigation)
Van Korlaar I. - Quality of life and risk perception in a large family with heritable protein C deficiency (IPCI: International Protein C Investigation)
Van Kraaij M. G. J. - Higher reticulated platelet counts and enhanced expression of P-selectin in patients with immune thrombocytopenic purpura compared to patients with myelodysplastic syndromes
Van Landeghem A. A. J. - Effects of genes and environmental factors on homocysteine level
Van Lier R. A. W. - A mouse model for inhibitor development in mild hemophilia A
Van Lier M. - Cholesterol-microdomains in platelet adhesion and aggregation
Van Lith-Zanders H. - Effect of the methionine synthase reductase A66G polymorphism on total homocysteine levels and venous thrombosis risk
Van Loon H. - The quality of care in the management of oral anti-coagulation therapy by the Belgian general practitioner
Van Lummel M. - Binding of b2-glycoprotein I and dimeric b2-glycoprotein I to members of the low-density lipoprotein receptor superfamily: implications for the anti-phospholipid syndrome
Van Marion V. - Co-segregation of Von Willebrands disease type 1 phenotype and Von Willebrand factor gene haplotypes: first results from the multicenter study molecular and clinical markers for the diagnosis and management of type 1 Von Willebrands disease
Van Marwijk Kooy M. R. - Observer variability in the assessment of clinical probability in patients with suspected pulmonary embolism
Van Meeteren M. - Thromboprophylaxis in orthopedic surgery: Clinical practice in the Netherlands
Van Mierlo P. J. W. B. - Effectiveness of excluding pulmonary embolism in the elderly by using a clinical decision rule and d-dimer
  - Thrombophilia strikes at all ages
Van Montfoort A. P. A. - Role of PI 3-kinase in glycoprotein VI-dependent calcium signaling in human platelets
Van Mourik J. A. - A mouse model for inhibitor development in mild hemophilia A
  - Factor VIII expression in liver disease
Van Mourik J. - Real-time imaging of the dynamics and secretary behavior of Weibel–Palade bodies
Van Mourik J. - The small GTP-binding protein Ral is involved in cAMP-mediated release of VWF from endothelial cells
Van Nguyen P. - Influence of thrombophilia on efficacy of warfarin for prevention of recurrent venous thromboembolism: results from a randomized trial
  - Influence of warfarin use on symptoms of fatigue: a randomized cross-over trial
Van Oerle R. - Local changes in coagulation and fibrinolysis in patients with a previous deep venous thrombosis
Van Ommen C. H. - Incidence and risk factors for factor VIII antibodies in mild hemophilia A
Van Ommen C. H. - The clinical outcome of pediatric venous thrombo-embolic disease in one tertiary centre
Van Oostayen J. A. - Common genetic abnormalities in blood coagulation (Factor V Leiden, prothrombin G20210A) increase the incidence of central vein catheter related thrombosis
Van Os E. - Thrombopoietin increases platelet adhesion and decreases rolling to von Willebrand factor
Van Pampus E. C. M. - Absolute risk of venous and arterial thromboembolism associated with mild hyperhomocysteinemia. Preliminary results of a family cohort study
  - Venous and arterial thromboembolic risk in first degree family members of patients with elevated plasma levels of clotting factor VIII:c
  - Storage of apheresis platelets leads to reduced adhesiveness and thrombogenic activity in flowing whole blood ex vivo
  - The risk of pregnancy complications in women from families with thrombophilic defects
  - Risk assessment of venous thromboembolism in pregnant women with factor V Leiden, prothrombin 20210 A mutation, elevated factor VIII levels or mild hyperhomocystinaemia
  - Absolute risk of venous thromboembolism (VTE) associated with a single or combined thrombophilic disorder. Preliminary results of a family cohort study
  - Increased risk for venous thromboembolism and myocardial infarction in family members of patients with prothrombin 20210 A mutation
Van Rhenen K. - Exposure of a binding site for the low-density lipoprotein receptor-related protein (LRP) upon activation of factor V
Van Rijn H. J. M. - The effect of oxidized low-density lipoprotein on the activation of platelets
  - PECAM-1 inhibits LDL-signaling in platelets
  - Platelet sensitization is mediated by Apolipoprotein E Receptor 2
Van Rooden C. J. - Prescribing anticoagulant prophylaxis in patients with hematological or solid tumor malignancies and central vein catheters: a nationwide survey
  - Common genetic abnormalities in blood coagulation (Factor V Leiden, prothrombin G20210A) increase the incidence of central vein catheter related thrombosis
Van Rooijen N. - Gene therapy for hemophilia A with high-capacity adenoviral vectors: preclinical evaluation in hemophilic mice and dogs
Van Rooijen M. - A relationship between SHBG and APCr during OC treatment
Van Scherpenzeel M. - Binding of b2-glycoprotein I and dimeric b2-glycoprotein I to members of the low-density lipoprotein receptor superfamily: implications for the anti-phospholipid syndrome
Van Stempvoort G. - Factor VIII – factor IX interactions probed by chimeric factor VIII/V variants: complex assembly and cofactor function involve different residues within the A3 domain region 1803–1818
  - Molecular events involved in factor IXa stimulation by the factor VIII A2 domain
  - Cleavage of factor VIII heavy chain by thrombin increases the affinity for low-density lipoprotein receptor-related protein (LRP)
Van Strijen M. J. L. - The role of spiral CT in alternative diagnosis in patients with clinical suspicion of pulmonary embolism
Van Tilburg N. H. - A comparison of assay methods for thrombin activatable fibrinolysis inhibitor (TAFI)
Van Tol A. - Alterations in lipoprotein homeostasis during experimental and clinical sepsis in primates
Van Trotsenburg M. - Recurrent pregnancy loss between the 8th and 15th week of gestation is not associated with an increased frequency of protein Z deficiency
Van Vliet H. H. D. M. - Use of double virus-inactivated factor VIII concentrate (Immunate®) as treatment of von Willebrand disease
Van Wijk R. - Characterization of an immunologic polymorphism in the heavy chain of human factor V, due to a dimorphism of residue 79
Van Willigen G. - Thrombopoietin increases platelet adhesion and decreases rolling to von Willebrand factor
Van Zanten A. P. - A two-stage thrombophilia screening protocol: more efficient use of laboratory tests
Vandenbroucke J. P. - Risk factors for recurrent venous thrombosis: a prospective follow-up of the Leiden thrombophilia study (LETS)
Vandendriessche T. - Gene therapy for haemophilias
  - Gene therapy for hemophilia A with high-capacity adenoviral vectors: preclinical evaluation in hemophilic mice and dogs
Vander Elst L. - An anti-idiotypic mouse monoclonal antibody towards idiotopes of human anti-C2 inhibitors mimics C2 the 3D conformation of C2 and restores Factor VIII activity in vivo
Vanderschoot J. P. M. - A new computer algorithm for better dosage of oral anti-coagulants
Vandervoort P. - Characterization of a lupus anticoagulant positive monoclonal antibody against human prothrombin
Vanhaeverbeek M. - A new Global Plasma Fibrinolytic Assay for the rapid analysis of hyper-/hypo-Fibrinolysis: relationship with blood lipids and inflammatory markers
Vanholder R. - The uremic retention solutes p-cresol and indoxyl sulfate inhibit endothelial proliferation and wound repair in vitro
Vanhoorelbeke K. - Identification of a novel inhibitory monoclonal antibody against the integrin a2b1
Vanhoorelbeke K. - Desaggregation of ristocetin-induced platelet aggregates by an inhibiting anti-GPIb MoAb
Vanhoorelbeke K. - The functional self association of von Willebrand factor is modulated by a multiple domain interaction
  - Binding of minute amounts of thrombin to GPIbalpha accelerates early platelet reactions, but not the platelet procoagulant response
Vanhoorelbeke K. - A new Von Willebrand ristocetin cofactor activity assay based on plasma glycocalicin
Vanhoorelbeke K. - A new platelet activation marker specific for activated integrin alpha2beta1: monoclonal antibody IAC-1
  - The platelet glycoprotein Ibalpha HPA-2 polymorphism affects VWF binding, but not thrombin interaction
  - Glycoprotein IX Asn45Ser: an ancestral mutation causing Bernard–Soulier syndrome in Europeans?
Vannier J. P. - Inhibition of angiogenesis by statins: a possible contribution for the protection of the vascular risk in atherosclerotic patients
  - Hypercoagulability in sickle cell disease: increased monocyte tissue factor expression and increased erythrocyte microparticles expressing phosphatidyl serine
  - Human endothelial cells synthesize Protein Z
Vannucchi H. - A transcobalamin gene polymorphism and the risk of deep venous thrombosis
Vanrusselt M. - Characterization of a lupus anticoagulant positive monoclonal antibody against human prothrombin
Vanschoonbeek K. - Effects of dietary fish oil on coagulation and platelets
  - Effects of platelet agonists and antiplatelet agents on thrombin formation in human plasma
Vanuzzo D. - NAD(P)H oxidase C242T gene variations and cardiovascular protection
Varadi K. - Monitoring the pharmacokinetic of inhibitor-bypassing agents with a new thrombin generation assay
  - Changes in ADAMTS13 (vWF cleaving protease) activity after induced acute release of von Willebrand factor
  - Analytical comparison of recombinant and plasma-derived activated protein C (APC)
Varfolomeyev S. D. - Fibronolytic properties of two-chain urokinase-type plasminogen activator attached to fibrinogen
  - Fibrin specificity of synergistic combined action of staphylokinase and single-chain urokinase-type plasminogen activator on in vitro clot lysis
Vargas R. N. - Venous thromboembolism (VTE) in children: a series of cases from a pediatric Brazilian cohort
Varghese R. - Plasma 13-HODE: A novel and powerful predictor of cardiovascular disease (CVD) risk and severity
Varlet M. N. - Venous thromboembolism during pregnancy and postpartum: results from a prospective cohort of women treated according to a risk score
Varma S. - Prevalence of factor V Leiden and FV HR2 haplotypes as risk factors for deep vein thrombosis: a study from north India
Varon D. - Cone and plate(let) analyzer as a diagnostic tool in various types of thrombotic thrombocytopenic purpura and haemolytic uremic syndrome
  - Cys61stop is the first identified nonsense mutation in the factor X gene causing severe factor X deficiency in 3 unrelated homozygotes of Arab origin
  - Efficacy and safety of two doses of enoxaparin in pregnant women with thrombophilia and recurrent pregnancy loss: the LIVE-ENOX study
  - Platelet-leukocyte aggregation under shear stress: Differential involvement of selectins and integrins
  - Monitoring the combined effect of integrilin, clopidogrel and aspirin in patients with myocardial infarction by Cone and Plate(let) Analyzer
Varsat B. - There is no north/south gradient distribution of the plasma fibrinogen level and of the C-148T Fg genotype in a French native population (The Fitenat Study)
  - Lack of correlation between HPA1 polymorphism and ADP induced platelet activation: study of a large cohort of normal subjects
Vartholomatos G. - Is the G455A polymorphism of the fibrinogen beta gene associated with osteonecrosis? A preliminary report
  - Mutations of the methylenetetrahydrofolate reductase (MTHFR) gene and osteonecrosis. A preliminary report
Varughese K. I. - Modulation of von Willebrand factor A1 domain binding to glycoprotein Iba by a-thrombin
  - Crystal structure of the amino terminal domain of glycoprotein Iba in complex with a-thrombin
Varvarikis C. - Plasma fibrinolytic capacity and 4G/5G polymorphism of PAI-1 gene in heart and kidney transplant recipients with or without steroid immunosuppression
Varvenne M. - The development of inhibitors directed against factor VIII after continuous infusion of factor VIII concentrates in patients with hemophilia A
  - New mutations in the fibrinogen genes of patients with dys, hypo- or fibrinogenemia
Vasiljev S. A. - Dynamics of changes of parameters of a hemostasis in patients with sepsis
Vasiloglou G. - Early therapeutic splenectomy may reduce morbidity and management costs in selected resistant or relapsing cases of TTP/HUS
Vasilyev S. A. - Laboratory (on base coagulological tests) it is latent proceeding hematogenous thrombophilias
  - Dynamics of changes of parameters of a hemostasis in patients with sepsis
Vasse M. - Hypercoagulability in sickle cell disease: increased monocyte tissue factor expression and increased erythrocyte microparticles expressing phosphatidyl serine
  - Human endothelial cells synthesize Protein Z
Vassy J. - Platelet aggregates modulate the adhesion of breast adenocarcinoma cells (MDA-MB-231) to endothelial cells and their matrix in whole blood and under flow conditions
Vaughan D. - PAI-1, arteriosclerosis and coronary thrombosis: insights from genetically modified mice
Vaughan D. E. - Chronic paclitaxel exposure increases human endothelial expression of plasminogen activator inhibitor-1, tissue-type plasminogen activator and tissue inhibitor of metalloproteinase-1
  - Differences in protease activated receptor-1 stimulation between vWF and P-selectin release in endothelial cells-implications of distinct signaling of Weibel–Palade release
Vaulin N. A. - Changes of hemostatic parameters in patients with non-ST elevation acute coronary syndrome treated with atorvastatin or pravastatin (randomized comparative study)
Vauterin S. - Identification of a novel inhibitory monoclonal antibody against the integrin a2b1
  - The functional self association of von Willebrand factor is modulated by a multiple domain interaction
  - The platelet glycoprotein Ibalpha HPA-2 polymorphism affects VWF binding, but not thrombin interaction
Vaux D. J. - A novel pathway of phospholipase Cg2 activation downstream of the platelet integrin aIIbb3
Vayá A. - The 4678G/C polymorphism in the endothelial protein C receptor (EPCR) gene reduces the risk of venous thromboembolism in carriers of the factor V Leiden mutation
  - Circulating activated protein C in Behcet's disease and risk of thrombosis
  - The 4678G/C polymorphism in the endothelial protein C receptor (EPCR) gene is associated with levels of soluble plasma EPCR
Vázquez C. - Quantitative real-time gene expression analysis for several components of fibrinolytic and matrix metalloproteinase systems in primary breast cancer
Vázquez R. - Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Vazquez R. - Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Vdovin V. V. - Cases of development of an idiopathic thrombocytopenic purpura at children associated with introduction of a tuberculin
  - Plasma glycocalicin level in diagnosis of the idiopathic thrombocytopenic purpura (ITP) in children
  - Results of clinical use of ‘NovoSeven’ in Russia
Vdovin V. V. - The experience of treatment of children with hemostasis system pathology treatment with recombinant factor VII NovoSeven
  - Using NovoSeven (NS) – recombinant factor VIIa to control the bleedings in Bernard-Soulier (BSS) girl. Case report
Vdovin V. V. - Idiopathic thrombocytopenic purpura at children, associated with a virus of rubella
  - The principles of therapy of hemorrhagic vasculitis at children
Vecchioli M. - Oral anti-coagulant therapy with POC device and remote computer monitoring in the setting of the Italian National Health System (INHS)
Vecchione G. - Endothelial nitric oxide synthase gene variation and hypertension in pregnancy
  - Prevalence of haemostatic abnormalities in women with 3 or more implantation failures after in vitro fertilization
Veeger N. J. G. M. - Individual variations of the level of oral anticoagulation in patients with venous thromboembolism (VTE) as predictor of clinical outcome
Veeger N. J. G. M. - High-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in congenital coagulation disorders. A randomized, double-blind, placebo-controlled clinical trial
Veenstra D. - Clinical outcomes and medical resource utilization in patients with and without malignancy treated with warfarin
Vega-Ostertag M. - Intracellular events in antiphospholipid-mediated platelet activation
Vegh P. - A pharmacokinetic study of tinzaparin in pediatric patients
  - Poor correlation between aPTT, anti-Xa levels and heparin dose in children receiving therapeutic doses of unfractionated heparin
  - A dose-finding study of Tinzaparin in pediatric patients
  - Ex vivo thrombin generation capacity in pediatric patients receiving Tinzaparin
Velan T. - Active thrombin concentrations and the rate of thrombin inhibition during cardiopulmonary bypass
Velasco F. - Increased tissue factor expression in monocytes from patients with anti-phospholipid syndrome depends on NFkB activation
  - A promising therapeutic strategy in acute promyelocytic leukemia (APL): disruption of MEK/ERK, arsenic and retinoids
Veldman A. - Protein C activation and possible use in different disease states - Neonatal sepsis
Vele O. - Induction of fractalkine by endothelial cells under shear stress
Vemulapalli S. - Antithrombotic effects of selective P2Y1 and P2Y12 antagonists in anesthetized rats
Venco A. - Determinants of delayed thrombus regression after deep vein thrombosis of the lower limbs: a prospective cohort study
  - Weight changes after acute deep venous throbosis: a prospective observational study
  - Early developments of the post-thrombotic syndrome in overweight and obese patients
Vene N. - Safety of the transfer of patients on anticoagulant therapy from hospital anticoagulant clinics to general practitioners using a computer-decision support
Ventura J. S. - Platelet responses mediated by venom snake metalloproteases (MP1 and MP3)
Verbeuren T. J. - Anti-thrombotic and anticoagulant effects of S35898 an orally active thrombin inhibitor
  - Specific phosphatidylserine exposure and microparticules shedding induced by a synthetic peptide
  - Evolution of a nonocclusive deep vein thrombosis in the rabbit vena cava
  - Role of NADPH oxidase on mechanisms implicated in anoxia/reoxygenation-induced leukocyte adhesion to HUVECs
  - Influence of selective nonpeptide PAR-1 and PAR-4 antagonists on thrombin-induced aggregation of human platelets
Verbruggen H. - Long-term in vivo platelet presensitization may explain the mechanism of factor VIIa prophylaxis in factor VII-deficient patients
Verbruggen B. - The Nijmegen low-titer factor VIII inhibitor assay: a highly sensitive assay for the detection of low-titer factor VIII inhibitors
Verbruggen H. - Evaluation of the surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic approach to determine Glanzmann Thrombasthenia in blood platelet lysates
Verbruggen H. W. - Higher reticulated platelet counts and enhanced expression of P-selectin in patients with immune thrombocytopenic purpura compared to patients with myelodysplastic syndromes
Vercamer C. - Effect of in vivo thrombin inhibition on bFGF-induced angiogenesis in a murine angiogenic model
Verdi H. - Role of genetic factors in vascular access thrombosis
  - Factor XIII Val34Leu polymorphism in Turkish population
  - Alpha-fibrinogen Thr 312 Ala polymorphism in Turkish population
  - Thrombotic risk factors in stroke patients
Verdy E. - Inherited thrombophilia is not associated with an increased risk of intrauterine fetal death
Verelst K. - Use of double virus-inactivated factor VIII concentrate (Immunate®) as treatment of von Willebrand disease
Vereycken-Holler V. - Platelet translocation on von Willebrand factor is inhibited by RGDS peptide at high shear rate
  - Irradiated endothelial cells promote platelet aggregates at high wall shear rate
Vergis J. - ‘Video Grand Rounds’: an assessment of internet based grand rounds to increase collaboration between comprehensive hemophilia treatment centers
Vergona R. - Development of small molecule compounds that inhibit PAI-1 activity in vitro and in vivo
Vergura P. - Women with common prothrombotic mutations are not at higher risk of recurrent intrauterine fetal deaths
Verhamme I. - Mechanisms of conformational activation of prothrombin by staphylocoagulase and fibrinogen substrate recognition
Verheijen J. H. - Tissue-type plasminogen activator (t-PA) gene deletion in apoE3-Leiden mice delays progression of cholesterol-induced atherosclerotic lesion
Verheyen C. C. P. M. - Day-care or short-stay surgery and venous thromboemolism: an overview
Verlato F. - Correlation between internal carotid artery stenosis and hematological risk factors for thrombosis (CAST study): final results
  - Different thromboprophylaxis approaches in patients undergoing knee arthroscopy (KANT study): interim report of prospective randomized study
Verlato F. - Management of hospitalized patients with suspected deep vein thrombosis
Vermeer C. - Mutations in genes of the gamma-glutamyl carboxylase and the vitamin K epoxidase reductase complex are responsible for the phenotype of hereditary combined deficiency of vitamin K-dependent clotting factors
Vermes E. - Aspirine resistance: a particularly high prevalence in patients after ventricular assist device implantation
Vermylen J. - The Gs agonist PACAP(1–38) is a physiological inhibitor of platelet aggregation and megakaryocyte maturation
  - P2X1-induced activation of Ca2+ calmodulin leads to myosin light chain and ERK2 phosphorylation in human platelets
  - Diesel exhaust particles deposited in the lung enhance thrombus formation in peripheral vessels in an in vivo model of vascular thrombosis
  - Characterization of a lupus anticoagulant positive monoclonal antibody against human prothrombin
  - Functional polymorphisms in the paternally expressed XLas and its cofactor ALEX decrease their mutual interaction and enhance receptor-mediated cAMP formation resulting in platelet Gs hyperfunction
  - Role of pulmonary inflammation on the peripheral thrombotic risk following intratracheal instillation of diesel exhaust particles
  - Deletion of residue Ala2201 in the factor VIII C2 domain impairs FVIII interactions with phospholipids and vWF and results in mild hemophilia A
  - Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype
  - The quality of care in the management of oral anti-coagulation therapy by the Belgian general practitioner
  - Platelet recruitment in vivo to injured blood vessels is not prevented by GPIIb/IIIa antagonism
  - Response to DDAVP in mild/moderate hemophilia A patients according to the underlying factor VIII genotype
Vernersson E. - Global hemostatic tests, protein C and anti-thrombin in the intensive care unit setting; correlations and ability to predict outcome
Verpillat P. - The Asp299Gly polymorphism of Toll-like receptor 4 as a genetic risk factor for acute coronary events
Verschuur M. - The -148C/T variation in the human fibrinogen b promoter influences basal and IL-6 induced transcription and affects binding of nuclear proteins
Versluys D. - Anti-thrombotic and anticoagulant effects of S35898 an orally active thrombin inhibitor
Verso M. - A double-blind placebo-controlled randomized study on the efficacy and safety of enoxaparin for the prevention of upper limb deep vein thrombosis in cancer patients with central vein catheter
Versteeg H. - Tissue factor/factor Vlla interaction induces activation of the pro-inflammatory JAK/STAT pathway
Verstuyft C. - Variations of INR and Factor VII Level are linked to Cytochrome P450 2C9 genotype
Vesela P. - Resveratrol and trolox scavenge hydroxyl radicals produced in platelets activated by collagen
  - Resveratrol and trolox scavenge hydroxyl radicals produced in platelets activated by collagen
Vesely S. - Long-term outcomes following recovery from thrombotic thrombocytopenic purpura – hemolytic uremic syndrome (TTP-HUS) measured by health-related quality-of-life (QOL) assessments
  - Complications of plasma exchange in thrombotic thrombocytopenic purpura–hemolytic uremic syndrome (TTP-HUS): A study of 149 consecutive patients 1996–2002
  - Analysis of ADAMTS13 activity in consecutive patients with clinically diagnosed thrombotic thrombocytopenic purpura – hemolytic uremic syndrome (TTP-HUS)
Veyradier A. - Identification of seven new candidate mutations of ADAMTS13 gene in four French families related to congenital thrombotic thrombocytopenic purpura
Vial C. - A key role of the fast ATP-gated P2X1 cation channel in the thrombosis of small arteries in vivo
  - A key role of the fast ATP-gated P2 X 1 cation channel in the thrombosis of small arteries in vivo
Vianello F. - Factor VII deficiency associated with severe hemophilia A
Vianello M. - Heterogeneous molecular pattern of Factor VII deficiency associated to cerebral hemorrhage
Vicari F. - Hemostasis and inflammation in advanced heart failure and after successful heart transplantation
Vicente V. - Mutations in the shutter region of anti-thrombin result in severe episodic thrombosis and unlike other serpins in formation of disulfide-linked dimers
  - Genetic variations of the extra-large stimulatory G protein a-subunit and risk of thrombotic and hemorrhagic disorders
  - Conformational basis of homozygous heparin cofactor II deficiency confirms critical role of P17 glutamate in serpins
  - Pharmacogenetics in the thrombolytic treatment of myocardial infarction: role of the FXIII V34L polymorphism
  - Detection of conformational transformation of antithrombin in blood by crossed immunoelectrophoresis: new application for a classical method. Effect of temperature in plasmatic antithrombin; role in senescence of antithrombin and thrombosis
  - Analysis of the HPS-1 gene in patients with single platelet dense-granule deficiency and mild bleeding diathesis
Vicini P. - Pharmacokinetics of recombinant human FXIII in cynomolgus monkeys
Vickers M. A. - Procoagulant changes in human macrophages induced by environmental microparticles [PM10]: a possible pathogenetic mechanism in cardiovascular disease
Vidal C. - Human platelet microparticles shedding is independent of the Cdc42/Rac1/PAK Pathway
Viegas E. - Evaluating the interaction of allopurinol with the oral anticoagulants
Vieira J. G. H. - Use of a decision-making system based on the Fuzzy sets theory applied to the routine of results' release in the haemostasis laboratory: how to do it better and quicker
Vieira L. M. - Hemostatic parameters in Brazilian asymptomatic carriers of Factor V Leiden, prothrombin (G20210A) and methylenetetrahydrofolate reductase (C677T) mutations
  - Markers of hypercoagulability in Brazilian patients with DVT undergoing oral anti-coagulation therapy
Viel K. - Functional resequencing of the factor IX (f-IX) gene: identifying quantitative trait nucleotides (QTNs) underlying the variation in plasma f-IX activity levels in the GAIT project
  - Functional re-sequencing of the factor VIII (f-VIII) gene: identifying quantitative trait nucleotides (QTNs) underlying the variation in plasma f-VIII activity levels in the Gait Project
Vigh I. - Association between factor XIII Val34Leu polymorphism and risk of ischemic stroke in young patients
Vigh TH. - Important Role of FV G1691A and FII G20210A in women with pregnancy loss without apparent causes
Vigh T. - Clinical manifestations of the antiphospholipid syndrome in patients with highly elevated anticardiolipin antibodies
Vigilante M. - Occurrence of myocardial infarction and PAI-1 4G/5G and ACE I/D gene polymorphisms in patients on chronic dialysis
Vignoli A. - Role of polymorphonuclear (PMN) leukocyte activation in the formation of PMN-platelet aggregates in Essential Thrombocythemia (ET) and Polycythemia Vera (PV)
  - Effect of the LMWHs dalteparin and enoxaparin on tissue factor and thrombomodulin expression by endothelial cells
  - Low-molecular weight heparin (LMWH) enoxaparin counteracts the expression of endothelial cell tissue factor elicited by malignant cells
Vignolo A. - Low-molecular weight heparins (LMWH) modulate the functional adhesion of tumor cells to the vascular endothelium
Vigorito E. - Involvement of the p110d catalytic subunit of phosphatidylinositol 3-kinase in platelet spreading on fibrinogen
Vijgen J. - The quality of care in the management of oral anti-coagulation therapy by the Belgian general practitioner
Vila V. - Endothelial and angiogenesis activity in terminal heart failure and heart-transplant patients: a prospective study
Vila V. - Inflammation and thrombogenic activity in terminal heart failure patients and heart transplantation: a prospective study
Vila V. - Inflammation and thrombogenic activity in terminal heart failure patients and heart transplantation: a prospective study
Vilahur G. - Local blockade of the collagen binding domain to vWF-A3 with Saratin decreases thrombotic risk in human atherosclerotic lesions
  - Local blockade of vWF binding epitopes on damaged vessel wall exposed collagen with Saratin inhibits thrombotic risk at different hemodynamic conditions
Vilaire G. - Activation of the platelet integrin aIIbb3 by thermodynamic modulation of transmembrane helix associations
Villa G. - Factor VII polymorphisms and the risk of myocardial infarction in coronary atherosclerosis
Villa P. - The 4678G/C polymorphism in the endothelial protein C receptor (EPCR) gene reduces the risk of venous thromboembolism in carriers of the factor V Leiden mutation
  - Inflammation and thrombogenic activity in terminal heart failure patients and heart transplantation: a prospective study
  - Circulating activated protein C in Behcet's disease and risk of thrombosis
Villa V. - Endothelial and angiogenesis activity in terminal heart failure and heart-transplant patients: a prospective study
Villa P. - The 4678G/C polymorphism in the endothelial protein C receptor (EPCR) gene is associated with levels of soluble plasma EPCR
Villaça P. R. - Inherited prothrombotic risk factors in a Brazilian cohort with CVT
Villaça P. R. - Factor VII deficiency and stroke: case report
Villaça P. R. - Successful use of Arixtra® in a patient with PNH, Budd–Chiari syndrome and HIT
  - Acquired prothrombotic-associated factors in cerebral venous thrombosis (CVT)
Villalta S. - Subcutaneous adjusted-dose unfractionated heparin vs. fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism
  - Risk factors for venous thromboembolism in chronically bedridden patients admitted to the Hospice Unit
Villar A. - A retrospective evaluation of the use of B-domain deleted recombinant Factor VIII (ReFacto®) administered by continuous infusion during surgical procedures
Villard S. - Peptide decoys selected by phage display block in vitro and in vivo activity of a human anti-FVIII inhibitor
Villard S. - Studies of anti-idiotypic polyclonal antibodies developed against antihuman Factor VIII monoclonal antibodies
Villegas-Mendez A. - Impaired interaction of protein C Gla domain variants with the endothelial cell protein C receptor (EPCR)
Villela M. S. H. - Comparative analysis of methods for detection of Activated Protein C resistance: an analysis of 755 consecutive patients
Villela M. S. H. - Effects of isolated and combined use of ticlopidine, clopidogrel and aspirin on platelet function as evaluated by platelet aggregometry
Villela M. S. H. - Use of a decision-making system based on the Fuzzy sets theory applied to the routine of results' release in the haemostasis laboratory: how to do it better and quicker
Villemson A. L. - Development of novel delivery systems of aprotinin
Villeval J. L. - Platelet activation causes a metalloprotease-mediated down-regulation of GlycoproteinVI
Villoutreix B. O. - Anti-thrombin F229L: a new homozygous variant leading to spontaneous anti-thrombin polymerization in vivo and severe childhood thrombosis
  - Factor V New Brunswick: Ala221Val associated with FV deficiency reproduced in vitro and functionally characterized
  - Functional properties of recombinant factor Va mutated in a potential calcium-binding site
  - Changed inactivation pathway of factor Va by activated protein C in the presence of heparin
  - Molecular recognition in the protein C anticoagulant pathway
Villoutreix B. O. - Theoretical and experimental investigation of the D2194G subsitution in the C2 domain of coagulation factor V
Vincent L. - Inhibition of angiogenesis by statins: a possible contribution for the protection of the vascular risk in atherosclerotic patients
Vincent M. - Ischemia induces early and enhanced expression of a new transcription factor (6A3-5) in human and rat kidney vascular smooth muscle cells
Vincent D. - The platelet ADP receptor P2Y12 is a critical player on the pathway of aIIbb3 activation by multiple agonists
  - Anticoagulants (thrombin inhibitors) and aspirin synergize with P2Y12 receptor antagonism in thrombosis
  - P2Y12 regulates platelet adhesion/activation, thrombus growth and thrombus stability in injured arteries
Vincentelli A. - Tissue factor pathway in carotid atherosclerotic plaques: relationships with clinical patterns and risk factors
Vinciguerra C. - Three abnormal patterns for inversion breaking intron 1 of the FVIII gene
Vinciguerra C. - Clinical manifestation of severe hemophilia B ameliorated by Prothrombin 20210A
Vink R. - Recombinant factor VIIa reverses the anticoagulant effect of the long-acting pentasaccharide idraparinux in healthy volunteers
Vink R. - Optimal intensity of oral anti-coagulant therapy in patients with mechanical heart valves
Vink R. - The optimal duration of treatment with vitamin K antagonists in patients with a first episode of venous thromboembolism: a decision analytic approach
Violi F. - Enhanced TNF-a and oxidative stress in patients with heart failure: effect of TNF-a on platelet O2 production
  - Aggregometric evidence of a progressive reduction of platelet sensitivity to aspirin
  - A polyphenol mixture inhibits collagen induced platelet aggregation
  - Increased platelet superoxide anion production in patients with hypertension: role of AT1 receptors
  - Antioxidant effect of wine in human: role of polyphenols
  - Fibrinogen as predictor of ischemic stroke in patients with nonvalvular atrial fibrillation
Virtanen K. S. - Inhibition of P2Y12-receptor in vivo and in vitro in patients undergoing elective percutaneous coronary intervention (PCI)
Visconte C. - Thrombolysis induced by streptokinase or recombinant plasminogen activator (rt-PA) is improved by SSR182289A, a direct orally active thrombin inhibitor, in rabbit models of thrombosis
Visich J. E. - Pharmacokinetics of recombinant human FXIII in cynomolgus monkeys
Vispo N. S. - Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
  - Gene transfer of naked plasmid DNA encoding VEGF121 leads to revascularization of ischemic tissue in animal models of vascular diseases
Vissac A.-M. - A new Global Plasma Fibrinolytic Assay for the rapid analysis of hyper-/hypo-Fibrinolysis: relationship with blood lipids and inflammatory markers
Vissac A. M. - The clinical relevance of anti-b2-GP1 antibodies assays in the presence of antiphospholipid antibodies and/or lupus anticoagulant
  - Inflammation and endothelial dysfunction in patients with carotid stenosis
Visvikis S. - Phenotypic sensitivity to activated protein C in healthy families: importance of genetic components and environmental factors in the Stanislas Cohort
Viswabandya A. - Administration of gentamicin does not increase factor levels in severe hemophilia-B due to premature termination codons
Vitale S. - Transdermal hormone replacement therapy does not affect hemostasis and inflammation
Vitali M. S. - Development, scale up and characterization of the first regional high purity Factor VIII: the Argentinean experience
  - Preparation of prothrombin complex concentrate (PCC) at intermediate scale: first experience in Argentina
Vitkovsky Y. - Nitric oxide, cytokine and hemostasis in stroke
Vitkovsky YU. - Influence of peloidotherapy on hemostasis, cytokines productions and lymphocyte-platelet adhesion
  - Disseminated intravascular coagulation in surgary
Vitsenya M. - The influence of exercise and stress on markers of activation of coagulation and fibrinolysis in young postinfarction patients
Vizcarra E. - Hypercoagulability in cerebrovascular disease (CD): factor V Leiden, prothrombin G20210A and MTHFR C677T mutations and polymorphism in the annexin V kozac sequence
Vizintin T. - Safety of the transfer of patients on anticoagulant therapy from hospital anticoagulant clinics to general practitioners using a computer-decision support
Vlasin M. - Paradoxical effect of unfractionated heparin in combination with streptokinase on arterial recanalization
Vo H. C. - Molecular basis of the bleeding disorder caused by Prothrombin-Vancouver
Voest E. E. - Tissue-type plasminogen activator is a multiligand cross-b structure receptor
Vogel G. M. T. - Human cell-derived microparticles promote thrombus formation in vivo in a tissue factor-dependent manner
  - Potential reversal agents for the long-acting pentasaccharide idraparinux
  - Soluble tissue factor released by cultured human umbilical vein endothelial cells is microparticle-associated and triggers thrombus formation in vivo
Voinea M. - Effects of enoxaparin on high glucose induced activation of human endothelial cells
Volgmann T. - Expression and function of platelet glycoproteins in newborns and adults
Völkl D. - Towards the development of a recombinant von Willebrand factor-cleaving protease (ADAMTS-13)
Volkova M. V. - Molecular risk factors are important causes for the thrombosis in childhood
Volpe S. - Enhanced TNF-a and oxidative stress in patients with heart failure: effect of TNF-a on platelet O2 production
Volpe E. - The strong incidence of acquired and inherited thrombophilia in recurrent first trimester fetal loss
Volpone J. - Agreement between FXIII activity assays and calibrator plasma pools: the need for a FXIII reference standard with regulatory recognition
Volteas S. - Thromboprophylaxis in laparoscopic cholecystectomy: identification of a high-risk group of patients
Von Auer C. - The development of inhibitors directed against factor VIII after continuous infusion of factor VIII concentrates in patients with hemophilia A
Von Auer C. - Mild ADAMTS-13 deficiency in patients with ischemic stroke
Von Dem Borne P. A. KR. - Complex formation of Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) with fibrin(ogen)
Von Depka M. - New mutations in the fibrinogen genes of patients with dys, hypo- or fibrinogenemia
  - Expression of Plasminogen activator inhibitor-1 (PAI-1) mRNA in human ciliary processes and determination of PAI-1 in human aqueous humor
  - A mutation leading to a stop codon in the FVIII gene is the cause of severe canine Hemophilia A
Von Depka- Prodzinski M. - The development of inhibitors directed against factor VIII after continuous infusion of factor VIII concentrates in patients with hemophilia A
Von Eckardstein A. - Sinus venous thrombosis in children – a multifactorial etiology
Von Heymann C. - Management of refractory postoperative cardiac bleeding with recombinant Factor VIIa (rFVIIa): Cases reported to the hemostasis.com registry
Von Pape K.-W. - Discrepancies in potency assessment of B-domain deleted recombinant factor VIII among different one-stage factor VIII clotting assays
Von Sicard N. - Triatomine extrinsic pathway inhibitor (TEPI) from the blood sucking insect Dipetalogaster Maxima™
Voogt P. J. - High-dose interferon-alpha induction treatment combined with ribavirin for chronic hepatitis C in congenital coagulation disorders. A randomized, double-blind, placebo-controlled clinical trial
Voorberg J. - Inhibition of factor VIII binding to phospholipids by single-chain variable domain fragments indicates that F2200 plays a more important role than M2199 in membrane-binding
  - A mouse model for inhibitor development in mild hemophilia A
  - Novel approaches to determine the characteristics of ADAMTS13 inhibitors in patients with acquired TTP
  - Real-time imaging of the dynamics and secretary behavior of Weibel–Palade bodies
  - The small GTP-binding protein Ral is involved in cAMP-mediated release of VWF from endothelial cells
  - Cleavage of factor VIII heavy chain by thrombin increases the affinity for low-density lipoprotein receptor-related protein (LRP)
Voorbij H. A. M. - Coronary risk prediction and the role of C-reactive protein
Vorlova Z. - The C1 domain substitution His2155Asp severely reduces factor VIII binding to von Willebrand factor
  - Sensitivity and specificity of PFA-100® vs. bleeding time in the diagnosis of type 1 von Willebrand disease (VWD)
  - Molecular and clinical markers for the diagnosis and management of type 1 von Willebrand's disease (VWD): The progress of a European collaboration
  - Significant prevalence of the intron 1 factor VIII gene inversion among patients with severe haemophilia A in the Czech Republic
  - A human factor VIII inhibitor tolerating the endogenous FVIII with a unique A2 domain substitution in CRM + hemophilia A
Vorlova Z. - Good efficacy of low dosing regimen of a FVIII/vWF concentrate in patients with von Willebrand disease
Vorlova Z. - Evaluation of a new quantitative, rapid test (VWF-LIA) for the diagnosis of type 1 VWD
  - Co-segregation of Von Willebrands disease type 1 phenotype and Von Willebrand factor gene haplotypes: first results from the multicenter study molecular and clinical markers for the diagnosis and management of type 1 Von Willebrands disease
  - An improved multimeric analysis identifies a subgroup of patients with Type 1 von Willebrand disease characterized by reduced VWF:RCo/Ag ratio
Vormittag R. - C-reactive protein in patients with venous thromboembolism
Vorster H. H. - The effect of refined and red palm olein compared to sunflower oil on lipids and homeostatic factors in hyperfibrinogenemic patients
Vos H. L. - C/EBP
  - Linkage analysis of factor VIII and von Willebrand factor loci as quantitative trait loci
Vos P. - Plasma markers of hemostatic activation in patients with cancer and deep venous thrombosis
Vos H. L. - Identification of transcription factor binding sites for HNF1-alpha, FOXA2, HNF4-alpha, Sp1 and Sp3 in the human prothrombin gene enhancer
  - Activated factor V is inactivated by activated protein C in the absence of APC cleavage sites at Arg306, Arg506 and Arg679
  - The -148C/T variation in the human fibrinogen b promoter influences basal and IL-6 induced transcription and affects binding of nuclear proteins
  - Dimerization and multimerization defects of von Willebrand factor due to mutated cysteine residues
  - Tissue-specific regulation of protein S gene transcription
  - Screening for annexin A5 gene mutations and the risk of the C-1T mutation in venous thrombosis and myocardial infarction
  - Functional analysis of the prothrombin (PT) G20210A variation
  - C-Reactive protein (CRP) is not a strong inducer of tissue factor in human monocytes
Vos H. - A comparison of assay methods for thrombin activatable fibrinolysis inhibitor (TAFI)
Vos H. L. - Characterization of an immunologic polymorphism in the heavy chain of human factor V, due to a dimorphism of residue 79
Vossen C. - Heritability of clotting factors and the prothrombotic state: results from a large thrombophilic pedigree of French Canadian descent with Type I protein C deficiency
Vossen C. Y. - Quality of life and risk perception in a large family with heritable protein C deficiency (IPCI: International Protein C Investigation)
Vossen C. - Lower degree of protein C activation in protein C deficient individuals of a large kindred with type I PC deficiency, as measured by the level of APC-PCI complex
Vossen C. Y. - Questioning the questionnaire: a sensitivity analysis for data collection on venous thrombosis
  - Incidence of venous thrombosis in carriers of familial thrombophilia with a personal history of venous thrombosis
Vossen C. - Asymptomatic venous thrombosis is a frequent event in protein C deficiency: a systematic ultrasound assessment of 208 family members with the 3363-C insertion mutation (IPCI: International Protein C Investigation)
Vranckx R. - Protease-nexin-1 inhibits plasminogen activation-induced apoptosis of adherent cells
Vreys I. - Overexpression of the platelet P2X1 ion channel in transgenic mice generates a novel prothrombotic phenotype
Vu D. - Congenital afibrinogenemia: expression and analysis of novel mutations affecting fibrinogen assembly or secretion
Vu T. - Comparison of inherited and acquired thrombophilia in cerebral venous thrombosis and pulmonary embolism or deep vein thrombosis of the leg
Vukovich T. - C-reactive protein in patients with venous thromboembolism
  - Is inflammation involved in the development of thrombosis in patients with the lupus anticoagulant?
Vystavkin A. - Role of protein C system in the advancement of activation zone of coagulation: A two-dimensional mathematical model